NCT00903812View on ClinicalTrials.gov

IMPACT Non Hodgkins Lymphoma (NHL) Study

CompletedOBSERVATIONAL
Enrollment

1,837

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

March 31, 2014

Conditions
Non-Hodgkin's Lymphoma
Interventions
OTHER

No intervention

No intervention as observational study

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00903812 - IMPACT Non Hodgkins Lymphoma (NHL) Study | Biotech Hunter | Biotech Hunter